FDA has approved Wegovy® (semaglutide) an an injectable weight-loss medication for adults with obesity or excess weight with weight-related conditions.
WeGovy® is the latest FDA-approved medication for weight loss management. It has been designed specifically for individuals who have a body mass index (BMI) of 27 or higher, and are also struggling with obesity-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol.
This injectable prescription medication contains the active ingredient semaglutide, which works by mimicking a natural hormone in the body that helps regulate appetite and food intake. WeGovy® is administered once a week, making it a convenient option for those seeking long-term weight management.
WeGovy® has been clinically proven to help individuals lose weight and maintain the weight loss over a longer period of time. Studies have shown that clients who use WeGovy® in combination with a reduced-calorie diet and increased physical activity, lost significantly more weight than those who only followed a diet and exercise regimen.
WeGovy® not only helps decrease appetite, but it also slows down the emptying of the stomach, leading to a feeling of fullness and satiety for longer periods of time. This can result in reduced food intake and ultimately, weight loss.
If you have struggled with losing weight and keeping it off, despite following traditional methods such as dieting and exercising, you may be a good candidate for WeGovy®. It is also suitable for individuals with a BMI of 27 or higher and are experiencing obesity-related health conditions.
However, it is important to note that WeGovy® should not be used as a standalone treatment. It is meant to be used in conjunction with a healthy lifestyle and behavior changes for effective weight loss management.
Our team at Revia Aesthetics will conduct a thorough evaluation to determine if WeGovy® is the right option for you. We will also provide ongoing support and guidance throughout your weight loss journey.
.svg){kind=logo}